Align Technology price target raised to $235 from $220 at Piper Sandler

Piper Sandler analyst Jason Bednar raised the firm’s price target on Align Technology (ALGN) to $235 from $220 and keeps an Overweight rating on the shares. Based on the firm’s data set of several hundred U.S. orthodontic offices, U.S. ortho aligner volumes grew in Q1 for the first time in over four years and improved about 3-4 points vs. the second half of 2025. The all-important teen cohort also posted year-over-year growth in March and Q1, and also saw even greater sequential acceleration vs. the broader population. These results have Piper turning more vocal with its positive call on Align ahead of Q1 results, with U.S. Q1 volumes serving as a potential source of upside vs. expectations and a possible catalyst for multiple expansion.